| Name | Sante Of Chandler |
|---|---|
| Location | 825 South 94th Street, Chandler, Arizona |
| Certified By | Medicare |
| No. of Certified Beds | 70 |
| Occupancy Rate | 95% |
| Medicare ID (CCN) | 035283 |
| Legal Business Name | Sante Chandler Llc |
| Ownership Type | For Profit - Limited Liability Company |
| NPI Number | 1376834580 |
| Organization Name | SANTE CHANDLER LLC |
| Doing Business As | SANTE OF CHANDLER |
| Address | 825 S. 94th St., Chandler, AZ 85224 |
| Phone Number | 480-361-6636 |
News Archive
Prometheus Research LLC has formed the Prometheus Solutions group to help customers develop data-driven solutions, including dashboards and reports. The group will draw on expertise developed by the company in its ten years of building custom biomedical data management applications.
Celtaxsys, Inc., a clinical stage drug development company focused on developing novel therapies for inflammatory diseases, today announced the successful completion of a $40M Series D financing led by Domain Partners VIII. Additional investors in the financing include Lumira Capital, RMI Partners, Masters Capital Management and the Georgia Research Alliance Venture Fund.
People with pre-diabetes are significantly less likely to develop diabetes if their blood glucose levels are normalized in time, according to new research by the Colorado School of Public Health and the University of Colorado School of Medicine.
Behavioral therapies such as pelvic-floor-muscle training and bladder-control strategies can reduce incontinence episodes by more than 50 percent in men following prostate-cancer surgery, according to new research from the Center for Aging at the University of Alabama at Birmingham and the Birmingham/Atlanta Veterans Affairs Geriatric Research, Education and Clinical Center.
› Verified 1 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Prometheus Research LLC has formed the Prometheus Solutions group to help customers develop data-driven solutions, including dashboards and reports. The group will draw on expertise developed by the company in its ten years of building custom biomedical data management applications.
Celtaxsys, Inc., a clinical stage drug development company focused on developing novel therapies for inflammatory diseases, today announced the successful completion of a $40M Series D financing led by Domain Partners VIII. Additional investors in the financing include Lumira Capital, RMI Partners, Masters Capital Management and the Georgia Research Alliance Venture Fund.
People with pre-diabetes are significantly less likely to develop diabetes if their blood glucose levels are normalized in time, according to new research by the Colorado School of Public Health and the University of Colorado School of Medicine.
Behavioral therapies such as pelvic-floor-muscle training and bladder-control strategies can reduce incontinence episodes by more than 50 percent in men following prostate-cancer surgery, according to new research from the Center for Aging at the University of Alabama at Birmingham and the Birmingham/Atlanta Veterans Affairs Geriatric Research, Education and Clinical Center.
› Verified 1 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|